{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:54:31Z","timestamp":1794322471048,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.transci.2024.104048","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T17:10:27Z","timestamp":1734455427000},"page":"104048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes in patients with thrombotic microangiopathy associated with a trigger following plasma exchange: A systematic literature review"],"prefix":"10.1016","volume":"64","author":[{"given":"Shinya","family":"Kaname","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moh-Lim","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.104048_bib1","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.transci.2024.104048_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.transci.2024.104048_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025986","article-title":"Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan","volume":"100","author":"Chung","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.transci.2024.104048_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/1744-9987.12763","article-title":"Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment","volume":"23","author":"Raina","year":"2019","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2024.104048_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2024.104048_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transci.2024.104048_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/org.7.1.14027","article-title":"Plasma exchange therapy for thrombotic microangiopathies","volume":"7","author":"Nguyen","year":"2011","journal-title":"Organogenesis"},{"key":"10.1016\/j.transci.2024.104048_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z","article-title":"United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange","volume":"13","author":"Bandarenko","year":"1998","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104048_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2024.104048_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2024.104048_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2024.104048_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib14","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib15","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib16","unstructured":"Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). PRISMA 2020 Checklist. Available from: \u3008http:\/\/www.prisma-statement.org\/\u3009 (Accessed October 5, 2022)."},{"key":"10.1016\/j.transci.2024.104048_bib17","unstructured":"NICE. Methods for the development of NICE public health guidance (third edition). Available from: \u3008https:\/\/www.nice.org.uk\/process\/pmg4\/chapter\/appendix-f-quality-appraisal-checklist-quantitative-intervention-studies\u3009 (Accessed September 28, 2022)."},{"key":"10.1016\/j.transci.2024.104048_bib18","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/trf.14263","article-title":"Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy","volume":"57","author":"Epperla","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104048_bib19","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/trf.15534","article-title":"Approaching treatment of transplant-associated thrombotic microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus","volume":"59","author":"Jan","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104048_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104048_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/ajts.AJTS_123_17","article-title":"Therapeutic plasma exchange for pediatric nonrenal disease indications and outcomes: a single-center experience","volume":"12","author":"Margabandhu","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2024.104048_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2018.08.016","article-title":"Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation-associated thrombotic microangiopathy: an institutional experience","volume":"25","author":"Sartain","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10067-017-3793-4","article-title":"TMA secondary to SLE: rituximab improves overall but not renal survival","volume":"37","author":"Sun","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.transci.2024.104048_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.621609","article-title":"Complement factor I mutation may contribute to development of thrombotic microangiopathy in lupus nephritis","volume":"7","author":"Tseng","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.transci.2024.104048_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41409-022-01581-1","article-title":"Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study","volume":"57","author":"Yang","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.13654","article-title":"Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study","volume":"56","author":"Li","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.104048_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keq311","article-title":"Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan","volume":"50","author":"Chen","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.transci.2024.104048_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bcp.13808","article-title":"Thrombotic microangiopathy associated with gemcitabine use: presentation and outcome in a national French retrospective cohort","volume":"85","author":"Daviet","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transci.2024.104048_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bmt.2009.233","article-title":"Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange","volume":"45","author":"Kennedy","year":"2010","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.transci.2024.104048_bib30","article-title":"Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.transci.2024.104048_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transpl."},{"key":"10.1016\/j.transci.2024.104048_bib32","first-page":"56","article-title":"Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome","volume":"60","author":"Yeter","year":"2022","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.transci.2024.104048_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jca.21352","article-title":"Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant","volume":"30","author":"Mulay","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104048_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/ejh.13284","article-title":"Postsurgical thrombotic microangiopathy: case series and review of the literature","volume":"103","author":"Sridharan","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2024.104048_bib35","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/ndt\/gfq842","article-title":"Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients - a case series","volume":"26","author":"Lovric","year":"2011","journal-title":"Nephrol Dial Transpl."},{"key":"10.1016\/j.transci.2024.104048_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jca.20226","article-title":"Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience","volume":"25","author":"Douglas","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104048_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.transci.2018.02.012","article-title":"A multicenter experience of thrombotic microangiopathies in Turkey: the Turkish Hematology Research and Education Group (ThREG)-TMA01 study","volume":"57","author":"Tekg\u00fcnd\u00fcz","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2024.104048_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jca.21547","article-title":"Therapeutic plasma exchange in children: one center's experience","volume":"32","author":"Cortina","year":"2017","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104048_bib39","first-page":"282","article-title":"Therapeutic plasma exchange in pediatric patients: results from a single center","volume":"13","author":"Dalkiran","year":"2022","journal-title":"J Pediatr Intensive Care"},{"key":"10.1016\/j.transci.2024.104048_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092900","article-title":"Severe acute kidney injury in cardiovascular surgery: thrombotic microangiopathy as a differential diagnosis to ischemia reperfusion injury. a retrospective study","volume":"9","author":"Grigorescu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.transci.2024.104048_bib41","first-page":"939","article-title":"Clinical characteristics and risk factors for thrombotic microangiopathy in children with lupus nephritis","volume":"30","author":"Yin","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/JCMA.0000000000000344","article-title":"Difference in thrombotic microangiopathy between concurrently and previously diagnosed systemic lupus erythematosus","volume":"83","author":"Chen","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.transci.2024.104048_bib43","first-page":"169","article-title":"Clinical characteristics and prognosis of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Chen","year":"2021","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.transci.2024.104048_bib44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/1744-9987.12710","article-title":"Therapeutic plasma exchange outcomes in Cairo University Hospitals: 6 years experience","volume":"22","author":"Momtaz","year":"2018","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2024.104048_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/1319-2442.279936","article-title":"Clinical profile and outcomes of de novo posttransplant thrombotic microangiopathy","volume":"31","author":"Saikumar Doradla","year":"2020","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/bjh.17430","article-title":"Transplant-associated thrombotic microangiopathy and immune haematological complications following intestine-containing organ transplantation: experience from over 100 consecutive cases","volume":"193","author":"Thomas","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2024.104048_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.5455\/medscience.2021.11.379","article-title":"Etiological evaluation and the role of plasma exchange treatment in thrombotic microangiopathies: a retrospective analysis from Eastern Anatolia","volume":"11","author":"Hidayet","year":"2022","journal-title":"Med Sci"},{"key":"10.1016\/j.transci.2024.104048_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2024.104048_bib49","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies - role of antibody-mediated rejection","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib50","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1681\/ASN.20203110S1779b","article-title":"Does therapeutic plasma exchange improve kidney function in renal transplant-associated thrombotic microangiopathy?","volume":"31","author":"Nahmod","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/ijot.ijot_29_19","article-title":"Thrombotic microangiopathies postrenal transplantation","volume":"14","author":"Ganesh","year":"2020","journal-title":"Indian J Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15563650.2021.1948559","article-title":"Snakebite-associated thrombotic microangiopathy: an Australian prospective cohort study [ASP30]","volume":"60","author":"Noutsos","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.transci.2024.104048_bib53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.ajkd.2017.05.023","article-title":"Quinine-induced thrombotic microangiopathy: a report of 19 patients","volume":"70","author":"Page","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2024.104048_bib54","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.ekir.2020.02.443","article-title":"SAT-418 Renal outcomes in patients who had plasma exchange for microangiopathic haemolytic anaemia following viper bites - a study in Sri Lanka","volume":"5","author":"Senananda","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transci.2024.104048_bib55","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s10067-021-05627-5","article-title":"Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy","volume":"40","author":"Chen","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.transci.2024.104048_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10245330600938687","article-title":"Treatment of thrombotic microangiopathies with plasma exchange","volume":"12","author":"Basic-Jukic","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.transci.2024.104048_bib57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ndt\/gfac213","article-title":"Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristics","volume":"38","author":"Decaestecker","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transci.2024.104048_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2024.104048_bib59","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transci.2024.104048_bib60","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.transproceed.2010.02.029","article-title":"Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience","volume":"42","author":"Said","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:48:30Z","timestamp":1738572510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1473050224002295"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.104048","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in patients with thrombotic microangiopathy associated with a trigger following plasma exchange: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.104048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104048"}}